2024 Press Releases

11-13-24 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024

11-07-24 – ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024

10-08-24 – ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

08-13-24 – ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024

08-07-24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024

07-09-24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024

06-05-24 ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain

06-04-24 ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders

05-14-24 ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

05-08-24 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

04-09-24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

02-27-24 ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

02-16-24 ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

01-08-24 ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023